Missouri Baptist Hospital of Sullivan
Missouri Baptist Hospital of Sullivan was paid $17.80M by Medicaid between Jan 2018 and Dec 2024, across 108 billing codes. Its largest line is 99283, emergency room visit (moderate) — 16% of everything it billed.
33Billing provider infoMISSOURI BAPTIST HOSPITAL OF SULLIVAN
SULLIVAN, MO 63080
SULLIVAN, MO 63080
33aNPI1295743169assigned 08/04/2006
33bProvider typeRegistered Nurse
28Total paid$17.80M
24GClaims189,522
24DCodes billed108
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Registered Nurse providers in Missouri
Rank by total paid#2 of 95
Median peer was paid$14K
This provider vs. median1,288×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 22,760 | $3.78M | |
| 2019 | 21,578 | $3.24M | |
| 2020 | 18,165 | $1.73M | |
| 2021 | 25,524 | $1.20M | |
| 2022 | 35,180 | $2.51M | |
| 2023 | 38,210 | $2.88M | |
| 2024incomplete | 28,105 | $2.46M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 16% | 15,235 | 14,690 | $2.88M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 16% | 8,393 | 7,846 | $2.80M |
| X4011 | State-specific procedure code | 14% | 8,233 | 7,499 | $2.49M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 11% | 7,735 | 7,354 | $1.92M |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 6.6% | 30,108 | 27,292 | $1.18M |
| 80053 | Comprehensive metabolic panel | 4.4% | 25,557 | 23,304 | $786K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 4.4% | 5,171 | 4,938 | $776K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 2.9% | 5,185 | 5,017 | $523K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.9% | 10,040 | 9,216 | $510K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.5% | 982 | 944 | $273K |
| 71046 | Radiologic examination, chest; 2 views | 1.4% | 1,965 | 1,792 | $244K |
| 81001 | 1.3% | 6,092 | 5,751 | $238K |
96 more codes
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 1.3% | 1,404 | $236K |
| J3490 | Unclassified drugs | 1.3% | 3,902 | $225K |
| 71045 | Radiologic examination, chest; single view | 1.2% | 4,937 | $215K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.2% | 2,165 | $205K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,870 | $163K |
| 36415 | Collection of venous blood by venipuncture | <1% | 7,198 | $159K |
| Y7507 | <1% | 812 | $139K | |
| 84484 | <1% | 5,805 | $105K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,833 | $103K |
| 86900 | <1% | 601 | $100K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,118 | $96K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,148 | $96K |
| 86850 | <1% | 620 | $82K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 1,118 | $79K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,623 | $77K |
| 86901 | <1% | 600 | $76K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 4,383 | $69K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 310 | $62K |
| Y7506 | <1% | 488 | $56K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 999 | $54K |
| 80061 | Lipid panel | <1% | 2,391 | $53K |
| X4006 | <1% | 47 | $51K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 371 | $46K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 69 | $43K |
| 83690 | <1% | 2,594 | $41K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 534 | $38K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 1,111 | $32K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 164 | $26K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 334 | $23K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 155 | $20K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,513 | $19K |
| 81003 | <1% | 1,400 | $19K | |
| 76830 | Ultrasound, transvaginal | <1% | 94 | $19K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 161 | $18K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 660 | $16K |
| 87660 | <1% | 673 | $16K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 83 | $16K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 275 | $16K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 139 | $15K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 303 | $14K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 165 | $13K |
| 87480 | <1% | 497 | $13K | |
| 87631 | <1% | 43 | $13K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 72 | $12K |
| 83605 | <1% | 552 | $11K | |
| 87081 | <1% | 118 | $11K | |
| 87510 | <1% | 352 | $11K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 24 | $11K |
| 87430 | <1% | 49 | $11K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 288 | $11K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 72 | $10K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 135 | $9K |
| 84702 | <1% | 469 | $9K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 859 | $8K |
| G0472 | Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | <1% | 172 | $8K |
| 84703 | <1% | 393 | $7K | |
| 86803 | <1% | 106 | $6K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 51 | $6K |
| 97597 | <1% | 53 | $5K | |
| 80081 | <1% | 72 | $5K | |
| 87420 | <1% | 15 | $5K | |
| G0378 | Hospital observation service, per hour | <1% | 33 | $5K |
| 84439 | <1% | 257 | $5K | |
| 86780 | <1% | 12 | $5K | |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | <1% | 163 | $4K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 119 | $3K |
| 82077 | <1% | 199 | $3K | |
| G0475 | Hiv antigen/antibody, combination assay, screening | <1% | 105 | $2K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 58 | $2K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 24 | $2K |
| 85379 | <1% | 204 | $2K | |
| 83880 | <1% | 92 | $1K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 88 | $1K |
| 83655 | <1% | 24 | $1K | |
| 86592 | <1% | 178 | $673.71 | |
| 87040 | <1% | 44 | $550.26 | |
| 85027 | <1% | 88 | $501.41 | |
| 80143 | <1% | 42 | $451.60 | |
| 82043 | <1% | 82 | $407.24 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 32 | $387.17 |
| 82570 | <1% | 84 | $350.58 | |
| 80179 | <1% | 30 | $289.52 | |
| 82950 | <1% | 55 | $233.04 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 13 | $230.59 |
| 82803 | <1% | 13 | $208.50 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 40 | $204.32 |
| 82550 | <1% | 39 | $187.55 | |
| 81025 | <1% | 13 | $105.28 | |
| 86140 | <1% | 17 | $76.65 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 16 | $59.36 |
| 85730 | <1% | 14 | $53.37 | |
| 85610 | <1% | 18 | $42.68 | |
| 85652 | <1% | 17 | $39.90 | |
| 82962 | <1% | 15 | $31.44 | |
| J2704 | Injection, propofol, 10 mg | <1% | 24 | $27.11 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 12 | $16.79 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSCHWARM, TONY (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Missouri Baptist Hospital of Sullivan | Steelville, MO | $135K |
| Missouri Baptist Hospital of Sullivan | Cuba, MO | $131K |
| Missouri Baptist Hospital of Sullivan | Sullivan, MO | $109K |
| Missouri Baptist Hospital of Sullivan | Bourbon, MO | $16K |
| Missouri Baptist Hospital of Sullivan | Cuba, MO | $7K |
| Missouri Baptist Hospital of Sullivan | Steelville, MO | $1K |
| Missouri Baptist Hospital of Sullivan | Sullivan, MO | $1K |
| Missouri Baptist Hospital of Sullivan | Bourbon, MO | $1K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.